NCT06842108

Brief Summary

Diabetes mellitus being metabolic disorder, chronic in nature, is characterized by high levels of glucose in our blood, which often lead to organ dysfunction. Approximately 10.5 % of adult (20-79 years) have diabetes according to international Diabetes federation. Cardiorespiratory fitness (CRF) is the capability of our cardiopulmonary system to make oxygen available to our skeletal muscles during physical activities for prolonged time, and is known to be decreased with diabetes. Hemodynamic parameters are correlated with various cardiovascular disorders but little evidence of hemodynamic changes in diabetes patients is present and more studies must be done. This study aims to establish the link between hemodynamic changes and cardiopulmonary fitness in T2DM patients, which could inform clinical practices and interventions to improve management, reduce cardiovascular risks, and enhance the quality of life for these patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
162

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 13, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 24, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2025

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2025

Completed
Last Updated

February 24, 2025

Status Verified

February 1, 2025

Enrollment Period

6 months

First QC Date

February 13, 2025

Last Update Submit

February 19, 2025

Conditions

Keywords

Diabetes MellitusHemodynamic changes

Outcome Measures

Primary Outcomes (2)

  • hemodynamic changes

    it will be assessed through ΔHeart Rate and HRR1

    Immediately after performing test

  • Cardiorespiratory fitness

    it will be measured from VO2 max.

    immediately after performing test

Study Arms (1)

Controlled type 2 Diabetes Mellitus patients.

The data will be collected after taking consent from patients who will be undergoing ETT.

Other: Exercise tolerance test

Interventions

• The ETT will be performed using Bruce protocol. The Bruce protocol is a standardized treadmill exercise test used in Exercise Tolerance Testing (ETT) to evaluate cardiovascular fitness and diagnose heart conditions. This protocol is divided into seven stages, each stage duration is 3 minutes and date will be recorded at the end of the each stage. The recorded data will include heart Rate, Rate pressure product (∆RPP), HRR1 and Blood Pressure. STEP 1: Patient Preparation STEP 2: Consent and history: STEP 3: Start of ETT: • Graded Exercise STEP 4: Parameters Recorded During ETT: * Heart Rate: Monitoring heart rate response to exercise stress. * Exercise induced changes in heart rate (∆HR) along with change in rate pressure product (∆RPP) due to excercise intensity. STEP 5: Cardiopulmonary Fitness Assessment VO2 Max

Controlled type 2 Diabetes Mellitus patients.

Eligibility Criteria

Age30 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Type 2 diabetes mellitus patients

You may qualify if:

  • Subjects who agreed to sign the informed consent form.
  • Subject with an age group 30-50yrs.
  • Female and male.
  • Controlled type 2 Diabetes Mellitus patients.

You may not qualify if:

  • Patient performing any exercise.
  • cardiovascular diseases.
  • Patients with Cerebrovascular diseases.
  • Patients with Peripheral artery diseases.
  • Patients with pulmonary dysfunction.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

bahria university Health sciences campus karachi

Karachi, Sindh, 75300, Pakistan

RECRUITING

Related Publications (1)

  • Al-Mhanna SB, Batrakoulis A, Wan Ghazali WS, Mohamed M, Aldayel A, Alhussain MH, Afolabi HA, Wada Y, Gulu M, Elkholi S, Abubakar BD, Rojas-Valverde D. Effects of combined aerobic and resistance training on glycemic control, blood pressure, inflammation, cardiorespiratory fitness and quality of life in patients with type 2 diabetes and overweight/obesity: a systematic review and meta-analysis. PeerJ. 2024 Jun 14;12:e17525. doi: 10.7717/peerj.17525. eCollection 2024.

    PMID: 38887616BACKGROUND

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Diabetes Mellitus

Interventions

Exercise Test

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Heart Function TestsDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisRespiratory Function TestsDiagnostic Techniques, Respiratory SystemErgometryInvestigative Techniques

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
physiotherapist

Study Record Dates

First Submitted

February 13, 2025

First Posted

February 24, 2025

Study Start

October 1, 2024

Primary Completion

March 30, 2025

Study Completion

April 15, 2025

Last Updated

February 24, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations